MedPath

Skeletal Muscle Strain Injuries and the Connective Tissue: Characterization, Recovery and Optimal Treatment

Not Applicable
Completed
Conditions
Muscle Strain
Interventions
Procedure: Acute Early onset of rehabilitation
Procedure: Chronic Control
Procedure: Acute Delayed onset of rehabilitation
Procedure: Chronic Exercise
Registration Number
NCT02152098
Lead Sponsor
Bispebjerg Hospital
Brief Summary

Firstly, the investigators aim to study the biochemical, structural and functional changes associated with acute muscle strain injury in the acute phase and during rehabilitation in vivo. Specific factors present after the injury and their effects on connective tissue cells will be examined in vitro.

Secondly, the investigators will investigate individuals with chronic pain, scar tissue and inferior function after a previous muscle strain injury and test a specific rehabilitation program to alleviate pain and disabilities associated with the preceding muscle injury. The investigators have the following hypotheses:

1. Humoral growth factors and pro-inflammatory macrophages released into the injured area post strain injury stimulate formation of connective tissue in vitro.

2. Early onset of rehabilitation will be superior to a delayed start of rehabilitation for the healing process, in regards to structural improvement of tissue and better clinical function.

3. Scar tissue following a muscle strain injury is characterized by disorganized structure of connective tissue.

4. Mechanical loading in the form of heavy eccentric muscle activity for 12 weeks will lead to a local re-modeling of scar tissue, and result in improved function and reduced symptoms in patients with chronic pain and impaired function after a previous muscle injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • Acute muscle strain injury
  • Chronic muscle strain injury
  • Age above 18 years
Exclusion Criteria
  • Daily intake of non-steroidal anti-inflammatory drugs (NSAIDs) within three months prior to the injury
  • Smoking
  • Diabetes
  • Connective tissue and/or rheumatic diseases
  • Any observed organ dysfunctions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Acute Early onset of rehabilitationAcute Early onset of rehabilitationAcute Early onset of rehabilitation
Chronic controlChronic ControlChronic control
Acute Delayed onset of rehabilitationAcute Delayed onset of rehabilitationAcute Delayed onset of rehabilitation
Chronic ExerciseChronic ExerciseChronic Exercise
Primary Outcome Measures
NameTimeMethod
Return to full physical activityBaseline; Up to 30 weeks (estimated time frame maximum)

First time the subject is fully fit to take part in all types of physical activity post injury;

Secondary Outcome Measures
NameTimeMethod
Ultrasound imagesBaseline, 1 week, 2 weeks

Volume of hematoma

Structural changes of tissueBaseline, 12 weeks

Evaluation of tissue samples from injured muscle before and after rehabilitation program

Magnetic resonance imagesBaseline, 4 weeks, 6 weeks, 12 weeks, 6 months

Size of injured tissue; Size and location of hematoma; Measurement of muscle perfusion (indication of metabolic activity)

Strength measurementsBaseline, 4 weeks, 6 weeks, 9 weeks, 12 weeks, 6 months

Strength tests of injured muscle group compared to healthy muscle group on contralateral leg

Aspiration and characterization of inter-/ intramuscular fluid in the injured muscleBaseline, 3 -14 days

The aspirated fluid (hematoma/exudate) will be analyzed for released humoral factors, cell types present and its effect on human fibroblast proliferation

Trial Locations

Locations (1)

Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Bispebjerg Bakke 23, Building 8

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath